ConductScience.org, home

Trial · NCT04447846

Outcomes19

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYList Sorting Working Memory TestBaseline, Follow-up (6 months)
Subject 1 was unable to complete this assessment due to lack of understanding of the instructions. Subject 10 was unable to complete this assessment due to a system error, where the fully adjusted score was not obtained. Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.
T-scoreMEAN
SECONDARYPicture Vocabulary TestBaseline, Follow-up (6 months)
Subject 10 did not complete this assessment due to a technical issue where the fully adjusted score was not calculated. Subject 9 was withdrawn from the study prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.
T-scoreMEAN
SECONDARYSeizure FrequencyBaseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.score on a scaleMEAN
SECONDARYMigraine SeverityBaseline, Follow-up (6 months)Subject 7 misplaced this questionnaire and was not included in analysis. Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.score on a scaleMEAN
SECONDARYModified House Classification ScoresBaseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.score on a scaleMEAN
SECONDARYErhardt Developmental Prehension Assessment ScoresBaseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.MonthsMEAN
SECONDARYPediatric Evaluation of Disability Inventory Computer Adapted TestBaseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.score on a scaleMEAN
SECONDARYABILHAND QuestionnaireBaseline, Follow-up (6 months)Subject 7 misplaced this questionnaire and was not included in analysis. Subject 9 was withdrawn prior to the 6 month follow-up visit due to persistent side effect and was not included in analysis.score on a scaleMEAN
SECONDARYWechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or Wechsler Adult Intelligence Scale (WAIS-IV)Baseline, Follow-up (6 months)
Subjects 1 and 10 did not complete this questionnaire as they were too young. Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.
score on a scaleMEAN
SECONDARYPediatric Neurological Quality of Life (Neuro-QoL)Baseline, Follow-up (6 months)Subjects below the age of 18 completed the pediatric version of this questionnaire and were included in analysis.T-scoreMEAN
SECONDARYBehavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)Baseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.T-scoreMEAN
SECONDARYSocial Responsiveness Scale, Second Edition (SRS-2)Baseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.T-scoreMEAN
SECONDARYBehavioral Assessment System for Children, Third Edition (BASC-3)Baseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.T-scoreMEAN
SECONDARYScreen for Child Anxiety Related Disorders (SCARED)Baseline, Follow-up (6 months)
Subject 7 misplaced this assessment and was not included in analysis. Subject 9 was withdrawn from the study prior to the 6 month follow-up visit due to a persistent side effect and was not included in analysis.
score on a scaleMEAN
SECONDARYQuality of Life in Childhood Epilepsy Questionnaire (QOLCE-55)Baseline, Follow-up (6 months)
Subject 7 misplaced this assessment and was not included in analysis. Subject 9 was withdrawn prior to the 6 month follow-up appointment due to a persistent side effect and was not included in analysis.
score on a scaleMEAN
SECONDARYSafety of EpidiolexBaseline, Follow-up (6 months)EventsNUMBER
SECONDARYNeuroscoreBaseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up visit and not included in analysis.score on a scaleMEAN
SECONDARYPort-wine Birthmark ScoreBaseline, Follow-up (6 months)Subject 9 was withdrawn prior to the 6 month follow-up appointment and was not included in analysis.score on a scaleMEAN
SECONDARYAdult Neurological Quality of Life (Neuro-QoL)Baseline, Follow-up (6 months)Subjects above the age of 18 completed the pediatric version of this questionnaire and were included in analysis.T-scoreMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04447846/outcomes